Product/Composition:- | Molnupiravir |
---|---|
Strength:- | 200 mg |
Form:- | Oral capsule |
Reference Brands:- | Lagevrio®(Us & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Molnupiravir, an oral antiviral for mild to moderate COVID-19, is approved in countries like India, UK, and Japan, under brands such as Lagevrio (Merck) and Molnatris (Dr. Reddy’s). Though not FDA-approved for general use in the US, it's widely distributed across Asia, LATAM, and MENA. PharmaB2B platforms connect global buyers with certified Molnupiravir suppliers, ensuring bulk availability, fast shipping, and regulatory compliance.
Molnupiravir and Tocilizumab are high-demand COVID-19 treatments sourced globally through trusted PharmaB2B platforms. Molnupiravir (200 mg capsules, branded as Lagevrio, Molnatris, Molnunat) is used for mild to moderate cases, while Tocilizumab (IV and SC, branded as Actemra, Tocira) treats severe inflammation in hospitalized patients. Approved in the US, EU, and Asia, these products are available in bulk from verified manufacturers and exporters. PharmaB2B networks offer global distribution, regulatory-compliant sourcing, and competitive pricing. Connect with reliable suppliers today to ensure seamless supply chain solutions for hospitals, tenders, and distributors worldwide.